Bristol-Myers Executive Accused Of Insider Trading


[August 2012] -- Bristol-Myers Squibb Co. (BMY) executive Robert Ramnarine was charged with insider trading for making $311,361 in illegal profit by buying stock options in three companies targeted for acquisition.

The FBI arrested Ramnarine, 45, and he appeared today in federal court in Newark, New Jersey, where he was released on $250,000 bond. Ramnarine's jobs included executive director of pensions and savings investments and assistant treasurer for capital markets.

Click here for full article